How do I interpret my test results
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Your Test Results
I'd be happy to help you understand how to interpret your test results! This is an important part of your cancer care, and according to the NCCN Guidelines for Patients: Acute Lymphoblastic Leukemia, understanding your test results is essential for making informed decisions about your treatment.
General Approach to Test Results
Here's what you should know:
According to NCCN Guidelines, results from blood tests, bone marrow biopsies, and imaging studies work together to determine your treatment plan. Your test results aren't meant to be understood in isolation—they're pieces of a larger picture that your care team uses to guide your care.
Key Steps to Take:
-
Get copies of all your results
- Request written copies of blood tests, imaging results, and pathology reports
- Keep them organized in a file (physical or digital)
- Many hospitals now offer online patient portals where you can access results directly
-
Write down your questions
- Don't try to interpret results on your own
- Bring a list of questions to your appointments
- Bring someone with you to appointments to help take notes
-
Ask your care team to explain
- What each test measures
- What your specific numbers or findings mean
- How these results affect your treatment plan
Common Tests and What They Generally Measure
According to NCCN Guidelines, typical tests for ALL include:
- Complete Blood Count (CBC) - measures different types of blood cells
- Bone marrow aspirate and biopsy - confirms diagnosis and identifies specific leukemia characteristics
- Genetic/biomarker tests - identify mutations and proteins that help guide targeted treatment
- Chemistry panel - checks organ function and electrolytes
- Imaging studies - look for leukemia outside the bloodstream
Questions to Ask Your Care Team
To help you have a productive conversation with your doctors, consider asking:
-
"What does each of my test results show, and what does it mean for my specific situation?"
-
"Are there any genetic mutations or biomarkers in my leukemia, and what do they tell us about treatment options?"
-
"How do these results compare to what doctors typically see, and what does that mean for my prognosis?"
-
"Which results are most important for deciding my treatment plan, and why?"
-
"Can you explain this in writing or provide resources so I can understand it better?"
Important Reminders
According to NCCN Guidelines, your multidisciplinary care team (which includes your oncologist, nurses, pathologist, and other specialists) interprets your results in the context of your complete medical picture. Your oncologist will determine what your specific results mean for YOUR individual case — no two patients are exactly alike, even with similar test findings.
The NCCN Guidelines emphasize that you should:
- Keep your primary care physician informed
- Maintain a contact list for your entire care team
- Don't hesitate to ask questions—there are no "silly" questions when it comes to understanding your health
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2